Elvinger Hoss Prussen acted as Luxembourg legal counsel to Oaktree Acquisition Corp. II, a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, L.P. on its entry into a definitive business combination agreement with Alvotech Holdings S.A., a leading global biopharmaceutical company focused on the development and manufacture of biosimilar medicines for patients worldwide.
Partner Karl Pardaens led the Elvinger Hoss Prussen team composed of Associate Ozan Imrek.
